SciClone Buys China Rights to Anti-Nausea Drug

SciClone Pharmaceuticals has in-licensed China rights to Ondansetron RapidFilm, a product developed by APR Applied Pharma Research SA that uses thin-film technology to deliver an established nausea drug. The rapidly dissolving product is administered to treat side effects of nausea and vomiting following surgery, chemotherapy, and radiotherapy. More details... Stock Symbol: (NSDQ: SCLN)